The genetics of skin fragility

Annual Review of Genomics and Human Genetics

Volumn 15, Issue , 2014, Pages 245-268

  Has, Cristina ^a   Bruckner Tuderman, Leena ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

basement membrane; blister; cell adhesion; epidermolysis bullosa; Kindler syndrome

Indexed keywords

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL THERAPY; DIAGNOSTIC PROCEDURE; EPIDERMIS CELL; EXTRACELLULAR MATRIX; FOCAL ADHESION; GENE MUTATION; GENE THERAPY; GENETIC VARIABILITY; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MOLECULAR THERAPY; MOSAICISM; NONHUMAN; PHENOTYPE; REVERTANT; SKIN FRAGILITY; TRANSLATIONAL RESEARCH; EPIDERMIS; EPIDERMOLYSIS BULLOSA; GENETIC ASSOCIATION; METABOLISM; MUTATION; PATHOLOGY; SKIN;

EPIDERMIS; EPIDERMOLYSIS BULLOSA; GENETIC ASSOCIATION STUDIES; GENETIC THERAPY; HUMANS; MUTATION; PHENOTYPE; SKIN; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84906851753     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-090413-025540     Document Type: Article

References (140)

1. Almaani N, Liu L, Dopping-Hepenstal PJ, Lai-Cheong JE, Wong A, et al. 2011. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa. Acta Derm. Venereol. 91:262-66
2. Almaani N, Liu L, Harrison N, Tanaka A, Lai-Cheong J, et al. 2009. New glycine substitution mutations in type VII collagen underlying epidermolysis bullosa pruriginosa but the phenotype is not explained by a common polymorphism in the matrix metalloproteinase-1 gene promoter. Acta Derm. Venereol. 89:6-11
3. Atkinson SD, McGilligan VE, Liao H, Szeverenyi I, Smith FJ, et al. 2011. Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex. J. Investig. Dermatol. 131:2079-86
4. Aumailley M, Has C, Tunggal L, Bruckner-Tuderman L. 2006. Molecular basis of inherited skin-blistering disorders, and therapeutic implications. Expert Rev. Mol. Med. 8:1-21
5. Bass-Zubek AE, Godsel LM, Delmar M, Green KJ. 2009. Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr. Opin. Cell Biol. 21:708-16
6. Behrens DT, Villone D, Koch M, Brunner G, Sorokin L, et al. 2012. The epidermal basement membrane isacompositeofseparate laminin-orcollagen IV-containing networks connectedbyaggregated perlecan, but not by nidogens. J. Biol. Chem. 287:18700-9
7. Bolling MC, Jongbloed JD, Boven LG, Diercks GF, Smith FJ, et al. 2014. Plectin mutations underlie epidermolysis bullosa simplex in 8% of patients. J. Investig. Dermatol. 234:273-76
8. Bolling MC, Jonkman MF. 2009. Skin and heart: une liaison dangereuse. Exp. Dermatol. 18:658-68
9. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC III. 2008. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N. Engl. J. Med. 358:2787-95
10. Bruckner-Tuderman L. 2010. Dystrophic epidermolysis bullosa: pathogenesis and clinical features. Dermatol. Clin. 28:107-14
11. Bruckner-Tuderman L, Has C. 2012. Molecular heterogeneity of blistering disorders: the paradigm of epidermolysis bullosa. J. Investig. Dermatol. 132:E2-5
12. Bruckner-Tuderman L, Has C. 2014. Disorders of the cutaneous basement membrane zone-the paradigm of epidermolysis bullosa. Matrix Biol. 33:29-34
13. Bruckner-Tuderman L, McGrath JA, Robinson EC, Uitto J. 2010. Animal models of epidermolysis bullosa: update 2010. J. Investig. Dermatol. 130:1485-88
14. Bruckner-Tuderman L, McGrath JA, Robinson EC, Uitto J. 2013. Progress in epidermolysis bullosa research: summary of DEBRA International Research Conference 2012. J. Investig. Dermatol. 133:2121-26
15. Bruckner-Tuderman L, Payne AS. 2012. Epidermal and dermal adhesion. In Fitzpatrick's Dermatology in General Medicine, ed. K Wolff, L Goldsmith, SI Katz, B Gilchrest, AS Paller, DJ Leffell, pp. 569-85. New York: McGraw-Hill Med. 8th ed.
16. Bruckner-Tuderman L, Ruegger S, Odermatt B, Mitsuhashi Y, Schnyder UW. 1988. Lack of type VII collagen in unaffected skin of patients with severe recessive dystrophic epidermolysis bullosa. Dermato-logica 176:57-64
17. Bruckner-Tuderman L, Schnyder UW, Winterhalter KH, Bruckner P. 1987. Tissue form of type VII collagen from human skin and dermal fibroblasts in culture. Eur. J. Biochem. 165:607-11
18. Bubier JA, Sproule TJ, Alley LM, Webb CM, Fine JD, et al. 2010. A mouse model of generalized non-Herlitz junctional epidermolysis bullosa. J. Investig. Dermatol. 130:1819-28
19. Carulli S, Contin R, De Rosa L, Pellegrini G, De Luca M. 2013. The long and winding road that leads to a cure for epidermolysis bullosa. Regen. Med. 8:467-81
20. Castiglia D, Zambruno G. 2010. Molecular testing in epidermolysis bullosa. Dermatol. Clin. 28:223-29
21. Chiaverini C, Charlesworth AV, Youssef M, Cuny JF, Rabia SH, et al. 2010. Inversa dystrophic epider-molysis bullosa is caused by missense mutations at specific positions of the collagenic domain of collagen type VII. J. Investig. Dermatol. 130:2508-11
22. Cho RJ, Simpson MA, McGrath JA. 2012. Next-generation diagnostics for genodermatoses. J. Investig. Dermatol. 132:E27-28
23. Christiano AM, Greenspan DS, Hoffman GG, Zhang X, Tamai Y, et al. 1993. A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat. Genet. 4:62-66
24. Conget P, Rodriguez F, Kramer S, Allers C, Simon V, et al. 2010. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 12:429-31
25. Corrado D, Basso C, Pilichou K, Thiene G. 2011. Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Heart 97:530-39
26. Covaciu C, Grosso F, Pisaneschi E, Zambruno G, Gregersen PA, et al. 2011. A founder synonymous COL7A1 mutation in three Danish families with dominant dystrophic epidermolysis bullosa pruriginosa identifies exonic regulatory sequences required for exon 87 splicing. Br. J. Dermatol. 165:678-82
27. Dang N, Klingberg S, Rubin AI, Edwards M, Borelli S, et al. 2008. Differential expression of pyloric atresia in junctional epidermolysis bullosa with ITGB4 mutations suggests that pyloric atresia is due to factors other than the mutations and not predictive of a poor outcome: three novel mutations and a review of the literature. Acta Derm. Venereol. 88:438-48
28. Darling TN, Yee C, Bauer JW, Hintner H, Yancey KB. 1999. Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation. J. Clin. Investig. 103:1371-77
29. Davis BR, Candotti F. 2009. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol. Res. 44:127-31
30. Delva E, Tucker DK, Kowalczyk AP. 2009. The desmosome. Cold Spring Harb. Perspect. Biol. 1:a002543
31. Di Salvio M, Piccinni E, Di Zenzo G, Orecchia A, Cianfarani F, et al. 2012. Diverse TGF-beta signalling activation in fibroblasts from phenotypically discordant monozygotic twins with recessive dystrophic epidermolysis bullosa. J. Investig. Dermatol. 132:S91 (Abstr.)
32. DiPersio CM, Hodivala-Dilke KM, Jaenisch R, Kreidberg JA, Hynes RO. 1997. α3β1 integrinisrequired for normal development of the epidermal basement membrane. J. Cell Biol. 137:729-42
33. Domogatskaya A, Rodin S, Tryggvason K. 2012. Functional diversity of laminins. Annu. Rev. Cell Dev. Biol. 28:523-53
34. Drera B, Floriddia G, Forzano F, Barlati S, Zambruno G, et al. 2009. Branch point and donor splice-site COL7A1 mutations in mild recessive dystrophic epidermolysis bullosa. Br. J. Dermatol. 161:464-67
35. Duperret EK, Ridky TW. 2013. Focal adhesion complex proteins in epidermis and squamous cell carcinoma. Cell Cycle 12:3272-85
36. Fine JD. 1987. Altered skin basement membrane antigenicity in epidermolysis bullosa. Curr. Probl. Dermatol. 17:111-26
37. Fine JD, Bauer EA, Briggaman RA, Carter DM, Eady RA, et al. 1991. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa: a consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J. Am. Acad. Dermatol. 24:119-35
38. Fine JD, Bruckner-Tuderman L, Eady RA, Eady RA, Bauer EA, Bauer JW, et al. 2014. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J. Am. Acad. Dermatol. 70:1103-26
39. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, et al. 2008. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J. Am. Acad. Dermatol. 58:931-50
40. Franzke CW, Bruckner P, Bruckner-Tuderman L. 2005. Collagenous transmembrane proteins: recent insights into biology and pathology. J. Biol. Chem. 280:4005-8
41. Gache Y, Allegra M, Bodemer C, Pisani-Spadafora A, de Prost Y, et al. 2001. Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Hum. Mol. Genet. 10:2453-61
42. Gostyński A, Pasmooij AM, Jonkman MF. 2014. Successful therapeutic transplantation of revertant skin in epidermolysis bullosa. J. Am. Acad. Dermatol. 70:98-101
43. Grada A, Weinbrecht K. 2013. Next-generation sequencing: methodology and application. J. Investig. Dermatol. 133:e11
44. Green KJ, Getsios S, Troyanovsky S, Godsel LM. 2010. Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb. Perspect. Biol. 2:a000125
45. Groves RW, Liu L, Dopping-Hepenstal PJ, Markus HS, Lovell PA, et al. 2010. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J. Investig. Dermatol. 130:1551-57
46. Hamilton BA, Yu BD. 2012. Modifier genes and the plasticity of genetic networks in mice. PLoS Genet. 8:e1002644
47. Harrison C, Kiladjian JJ, Al-Ali HK, Gisslinger H, Waltzman R, et al. 2012. JAK inhibition with rux-olitinib versus best available therapy for myelofibrosis. N. Engl. J. Med. 366:787-98
48. Has C, Bruckner-Tuderman L, Uitto J. 2013. Epidermolysis bullosa. In Emery and Rimoin's Principles and Practice of Medical Genetics, ed. DL Rimoin, RE Pyeritz, BR Korf, pp. 1-24. Amsterdam: Elsevier. 6th ed.
49. Has C, Castiglia D, del Rio M, Diez MG, Piccinni E, et al. 2011. Kindler syndrome: extension of FERMT1 mutational spectrum and natural history. Hum. Mutat. 32:1204-12
50. Has C, Kern JS. 2010. Collagen XVII. Dermatol. Clin. 28:61-66
51. Has C, Kiritsi D, Mellerio JE, Franzke CW, Wedgeworth E, et al. 2014. The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling Kindler syndrome. J. Investig. Dermatol. 134:845-49
52. Has C, Sparta G, Kiritsi D, Weibel L, Moeller A, et al. 2012. Integrin α3 mutations with kidney, lung, and skin disease. N. Engl. J. Med. 366:1508-14
53. Hashimoto I, Anton-Lamprecht I, Gedde-Dahl T Jr, Schnyder UW. 1975. Ultrastructural studies in epidermolysis bullosa heriditaria. I. Dominant dystrophic type of Pasini. Arch. Dermatol. Forsch. 252:167-78
54. Hilal L, Rochat A, Duquesnoy P, Blanchet-Bardon C, Wechsler J, et al. 1993. A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa. Nat. Genet. 5:287-93
55. Hintner H, Stingl G, Schuler G, Fritsch P, Stanley J, et al. 1981. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. J. Investig. Dermatol. 76:113-18
56. Hohenester E, Yurchenco PD. 2013. Laminins in basement membrane assembly. Cell Adhes. Migr. 7:56-63
57. Hovnanian A, Duquesnoy P, Blanchet-Bardon C, Knowlton RG, Amselem S, et al. 1992. Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J. Clin. Investig. 90:1032-36
58. Itoh M, Kiuru M, Cairo MS, Christiano AM. 2011. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 108:8797-802
59. Itoh M, Umegaki-Arao N, Guo Z, Liu L, Higgins CA, Christiano AM. 2013. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS ONE 8:e77673
60. Jobard F, Bouadjar B, Caux F, Hadj-Rabia S, Has C, et al. 2003. Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome. Hum. Mol. Genet. 12:925-35
61. Jonkman MF, Pasmooij AM. 2009. Revertant mosaicism-patchwork in the skin. N. Engl. J. Med. 360:1680-82
62. Jonkman MF, Pasmooij AM, Pasmans SG, van den Berg MP, Ter Horst HJ, et al. 2005. Loss of desmo-plakin tail causes lethal acantholytic epidermolysis bullosa. Am. J. Hum. Genet. 77:653-60
63. Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, et al. 1997. Revertant mosaicism in epider-molysis bullosa caused by mitotic gene conversion. Cell 88:543-51
64. Kern JS, Gruninger G, Imsak R, Muller ML, Schumann H, et al. 2009. Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort. Br. J. Dermatol. 161:1089-97
65. Kern JS, Loeckermann S, Fritsch A, Hausser I, Roth W, et al. 2009. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol. Ther. 17:1605-15
66. Kiritsi D, Cosgarea I, Franzke CW, Schumann H, Oji V, et al. 2010. Acral peeling skin syndrome with TGM5 gene mutations may resemble epidermolysis bullosa simplex in young individuals. J. Investig. Dermatol. 130:1741-46
67. Kiritsi D, He Y, Pasmooij AM, Onder M, Happle R, et al. 2012. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination. J. Clin. Investig. 122:1742-46
68. Kiritsi D, Kern JS, Schumann H, Kohlhase J, Has C, Bruckner-Tuderman L. 2011. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa. J. Med. Genet. 48:450-57
69. Kiritsi D, Pigors M, Tantcheva-Poor I, Wessel C, Arin MJ, et al. 2013. Epidermolysis bullosa simplex Ogna revisited. J. Investig. Dermatol. 133:270-73
70. Koebner H. 1886. Hereditäre Anlage zur Blasenbildung (epidermolysis bullosa hereditare). Dtsch. Med. Wochenschr. 12:21-22
71. Koga H, Hamada T, Ishii N, Fukuda S, Sakaguchi S, et al. 2011. Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa. J. Dermatol. 38:489-92
72. Koss-Harnes D, Hoyheim B, Anton-Lamprecht I, Gjesti A, Jorgensen RS, et al. 2002. A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations. J. Investig. Dermatol. 118:87-93
73. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, et al. 1996. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122:3537-47
74. Krunic AL, Stone KL, Simpson MA, McGrath JA. 2013. Acral peeling skin syndrome resulting from a homozygous nonsense mutation in the CSTA gene encoding cystatin A. Pediatr. Dermatol. 30:e87-88
75. Kuschal C, DiGiovanna JJ, Khan SG, Gatti RA, Kraemer KH. 2014. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons. Proc. Natl. Acad. Sci. USA 110:19483-88
76. Laimer M, Lanschuetzer CM, Diem A, Bauer JW. 2010. Herlitz junctional epidermolysis bullosa. Dermatol. Clin. 28:55-60
77. Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, et al. 2010. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol. Ther. 18:442-46
78. Liu L, Dopping-Hepenstal PJ, Lovell PA, Michael M, Horn H, et al. 2012. Autosomal recessive epider-molysis bullosa simplex due to loss of BPAG1-e expression. J. Investig. Dermatol. 132:742-44
79. Margadant C, Charafeddine RA, Sonnenberg A. 2010. Unique and redundant functions of integrins in the epidermis. FASEB J. 24:4133-52
80. Marinkovich MP, Lunstrum GP, Keene DR, Burgeson RE. 1992. The dermal-epidermal junction of human skin contains a novel laminin variant. J. Cell Biol. 119:695-703
81. Marinkovich MP, Verrando P, Keene DR, Meneguzzi G, Lunstrum GP, et al. 1993.Basementmembrane proteins kalinin and nicein are structurally and immunologically identical. Lab. Investig. 69:295-99
82. Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, et al. 2006. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat. Med. 12:1397-402
83. McGrath JA, Bolling MC, Jonkman MF. 2010. Lethal acantholytic epidermolysis bullosa. Dermatol. Clin. 28:131-35
84. McGrath JA, Gatalica B, Christiano AM, Li K, Owaribe K, et al. 1995. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat. Genet. 11:83-86
85. McGrath JA, McMillan JR, Shemanko CS, Runswick SK, Leigh IM, et al. 1997. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat. Genet. 17:240-44
86. McGrath JA, Stone KL, Begum R, Simpson MA, Dopping-Hepenstal PJ, et al. 2012. Germline mutation in EXPH5 implicates the Rab27B effector protein Slac2-b in inherited skin fragility. Am. J. Hum. Genet. 91:1115-21
87. Nekrasova O, Green KJ. 2013. Desmosome assembly and dynamics. Trends Cell Biol. 23:537-46
88. Nicolaou N, Margadant C, Kevelam SH, Lilien MR, Oosterveld MJ, et al. 2012. Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome. J. Clin. Investig. 122:4375-87
89. Nystrom A, Velati D, Mittapalli VR, Fritsch A, Kern JS, Bruckner-Tuderman L. 2013. Collagen VII plays a dual role in wound healing. J. Clin. Investig. 123:3498-509
90. Odorisio T, Di Salvio M, Orecchia A, Di Zenzo G, Piccinni E, et al. 2014. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity. Hum. Mol. Genet. In press. doi: 10.1093/hmg/ddu102
91. Pacho F, Zambruno G, Calabresi V, Kiritsi D, Schneider H. 2011. Efficiency of translation termination in humans is highly dependent upon nucleotides in the neighbourhood of a (premature) termination codon. J. Med. Genet. 48:640-44
92. Pasmooij AM, Garcia M, Escamez MJ, Nijenhuis AM, Azon A, et al. 2010. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa. J. Investig. Dermatol. 130:2407-11
93. Pasmooij AM, Jonkman MF. 2013. Analysis of cutaneous somatic mosaicism. Methods Mol. Biol. 961:165-77
94. Pasmooij AM, Jonkman MF, Uitto J. 2012. Revertant mosaicism in heritable skin diseases-mechanisms of natural gene therapy. Discov. Med. 14:167-79
95. Pasmooij AM, Nijenhuis M, Brander R, Jonkman MF. 2012. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J. Investig. Dermatol. 132:1374-83
96. Pasmooij AM, Pas HH, Deviaene FC, Nijenhuis M, Jonkman MF. 2005. Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am. J. Hum. Genet. 77:727-40
97. Pearson RW. 1962. Studies on the pathogenesis of epidermolysis bullosa. J. Investig. Dermatol. 39:551-75
98. Petrof G, Martinez-Queipo M, Mellerio JE, Kemp P, McGrath JA. 2013. Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial. Br. J. Dermatol. 169:1025-33
99. Petrof G, Mellerio JE, McGrath JA. 2012. Desmosomal genodermatoses. Br. J. Dermatol. 166:36-45
100. Pigors M, Kiritsi D, Cobzaru C, Schwieger-Briel A, Suarez J, et al. 2012. TGM5 mutations impact epidermal differentiation in acral peeling skin syndrome. J. Investig. Dermatol. 132:2422-29
101. Pigors M, Kiritsi D, Krumpelmann S, Wagner N, He Y, et al. 2011. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum. Mol. Genet. 20:1811-19
102. Pigors M, Schwieger-Briel A, Leppert J, Kiritsi D, Kohlhase J, et al. 2014. Molecular heterogeneity of epidermolysis bullosa simplex: contribution of EXPH5 mutations. J. Investig. Dermatol. 134:842-45
103. Pohla-Gubo G, Cepeda-Valdes R, Hintner H. 2010. Immunofluorescence mapping for the diagnosis of epidermolysis bullosa. Dermatol. Clin. 28:201-10
104. Pruneddu S, Castiglia D, Floriddia G, Cottoni F, Zambruno G. 2011. COL7A1 recessive mutations in two siblings with distinct subtypes of dystrophic epidermolysis bullosa: pruriginosa versus nails only. Dermatology 222:10-14
105. Remington J, Wang X, Hou Y, Zhou H, Burnett J, et al. 2009. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol. Ther. 17:26-33
106. Rodeck CH, Eady RA, Gosden CM. 1980. Prenatal diagnosis of epidermolysis bullosa letalis. Lancet 315:949-52
107. Ruzzi L, Pas H, Posteraro P, Mazzanti C, Didona B, et al. 2001. A homozygous nonsense mutation in type XVII collagen gene (COL17A1) uncovers an alternatively spliced mRNA accounting for an unusually mild form of non-Herlitz junctional epidermolysis bullosa. J. Investig. Dermatol. 116:182-87
108. Ryynanen M, Knowlton RG, Parente MG, Chung LC, Chu ML, Uitto J. 1991. Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa. Am. J. Hum. Genet. 49:797-803
109. Ryynanen M, Knowlton RG, Uitto J. 1991. Mapping of epidermolysis bullosa simplex mutation to chromosome 12. Am. J. Hum. Genet. 49:978-84
110. Ryynanen M, Ryynanen J, Sollberg S, Iozzo RV, Knowlton RG, Uitto J. 1992. Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. J. Clin. Investig. 89:974-80
111. Sakai LY, Keene DR, Morris NP, Burgeson RE. 1986. Type VII collagen is a major structural component of anchoring fibrils. J. Cell Biol. 103:1577-86
112. Salam A, Simpson MA, Stone KL, Takeichi T, Nanda A, et al. 2014. Next generation diagnostics of heritable connective tissue disorders. Matrix Biol. 33:35-40
113. Schuilenga-Hut PH, Scheffer H, Pas HH, Nijenhuis M, Buys CH, Jonkman MF. 2002. Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex. J. Investig. Dermatol. 118:626-30
114. Schumann H, Kiritsi D, Pigors M, Hausser I, Kohlhase J, et al. 2013. Phenotypic spectrum of epider-molysis bullosa associated with α6β4 integrin mutations. Br. J. Dermatol. 169:115-24
115. Scott CA, Plagnol V, Nitoiu D, Bland PJ, Blaydon DC, et al. 2013. Targeted sequence capture and high-throughput sequencing in the molecular diagnosis of ichthyosis and other skin diseases. J. Investig. Dermatol. 133:573-76
116. Smith FJ, Morley SM, McLean WH. 2004. Novel mechanismofrevertant mosaicisminDowling-Meara epidermolysis bullosa simplex. J. Investig. Dermatol. 122:73-77
117. Sproule TJ, Bubier JA, Grandi FC, Sun VZ, Philip VM, et al. 2014. Molecular identification of collagen 17α1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice. PLoS Genet. 10:e1004068
118. Tamai K, Yamazaki T, Chino T, Ishii M, Otsuru S, et al. 2011. PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc. Natl. Acad. Sci. USA 108:6609-14
119. Titeux M, Pendaries V, Tonasso L, Decha A, Bodemer C, Hovnanian A. 2008. A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum. Mutat. 29:267-76
120. Tolar J, Ishida-Yamamoto A, Riddle M, McElmurry RT, Osborn M, et al. 2009. Amelioration of epi-dermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113:1167-74
121. Tolar J, Wagner JE. 2013. Allogeneic blood and bone marrow cells for the treatment of severe epider-molysis bullosa: repair of the extracellular matrix. Lancet 382:1214-23
122. Tolar J, Xia L, Lees CJ, Riddle M, McElroy A, et al. 2013. Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J. Investig. Dermatol. 133:562-65
123. Uitto J. 2012. Milestones in genetics of structural skin disorders. J. Investig. Dermatol. 132:E1
124. Van Agtmael T, Bruckner-Tuderman L. 2010. Basement membranes and human disease. Cell Tissue Res. 339:167-88
125. van den Akker PC, Mellerio JE, Martinez AE, Liu L, Meijer R, et al. 2011. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen. J. Med. Genet. 48:160-67
126. van den Akker PC, Nijenhuis M, Meijer G, Hofstra RM, Jonkman MF, Pasmooij AM. 2012. Natural gene therapy in dystrophic epidermolysis bullosa. Arch. Dermatol. 148:213-16
127. Vanacore RM, Shanmugasundararaj S, Friedman DB, Bondar O, Hudson BG, Sundaramoorthy M. 2004. The α1.α2 network of collagen IV: reinforced stabilization of the noncollagenous domain-1 by noncovalent forces and the absence of Met-Lys cross-links. J. Biol. Chem. 279:44723-30
128. Venugopal SS, Yan W, Frew JW, Cohn HI, Rhodes LM, et al. 2013. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. J. Am. Acad. Dermatol. 69:898-908
129. Villone D, Fritsch A, Koch M, Bruckner-Tuderman L, Hansen U, Bruckner P. 2008. Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils. J. Biol. Chem. 283:24506-13
130. Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, et al. 2010. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N. Engl. J. Med. 363:629-39
131. Walko G, Vukasinovic N, Gross K, Fischer I, Sibitz S, et al. 2011. Targeted proteolysis of plectin isoform 1a accounts for hemidesmosome dysfunction in mice mimicking the dominant skin blistering disease EBS-Ogna. PLoS Genet. 7:e1002396
132. Wessagowit V, Kim SC, Woong Oh S, McGrath JA. 2005. Genotype-phenotype correlation in recessive dystrophic epidermolysis bullosa: when missense doesn't make sense. J. Investig. Dermatol. 124:863-66
133. Wiche G, Winter L. 2011. Plectin isoforms as organizers of intermediate filament cytoarchitecture. Bioarchitecture 1:14-20
134. Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, et al. 2008. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J. Investig. Dermatol. 128:2179-89
135. Woodley DT, Krueger GG, Jorgensen CM, Fairley JA, Atha T, et al. 2003. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J. Investig. Dermatol. 121:1021-28
136. Woodley DT, Wang X, Amir M, Hwang B, Remington J, et al. 2013. Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J. Investig. Dermatol. 133:1910-13
137. Xu K, Nowak I, Kirchner M, Xu Y. 2008. Recombinant collagen studies link the severe conformational changes induced by osteogenesis imperfecta mutations to the disruption of a set of interchain salt bridges. J. Biol. Chem. 283:34337-44
138. Yancey KB, Hintner H. 2010. Non-Herlitz junctional epidermolysis bullosa. Dermatol. Clin. 28:67-77
139. Yang CS, Lu Y, Farhi A, Nelson-Williams C, Kashgarian M, et al. 2012. An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred. Pediatr. Dermatol. 29:725-31
140. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, et al. 2013. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N. Engl. J. Med. 369:1502-11